chr4-89248496-T-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198281.3(GPRIN3):c.1615A>C(p.Lys539Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,612,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K539R) has been classified as Uncertain significance.
Frequency
Consequence
NM_198281.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GPRIN3 | ENST00000609438.2 | c.1615A>C | p.Lys539Gln | missense_variant | Exon 2 of 2 | 2 | NM_198281.3 | ENSP00000476603.1 | ||
| GPRIN3 | ENST00000333209.4 | c.1615A>C | p.Lys539Gln | missense_variant | Exon 1 of 1 | 6 | ENSP00000328672.3 | |||
| GPRIN3 | ENST00000715382.1 | c.1615A>C | p.Lys539Gln | missense_variant | Exon 2 of 2 | ENSP00000520450.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000400 AC: 1AN: 250188 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460572Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 726468 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1615A>C (p.K539Q) alteration is located in exon 2 (coding exon 1) of the GPRIN3 gene. This alteration results from a A to C substitution at nucleotide position 1615, causing the lysine (K) at amino acid position 539 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at